CLDN5 and schizophrenia: While overall levels of protein were not changed, an aberrant pattern of claudin-5 immunoreactivity was observed in 62% of the schizophrenia cases—usually claudin-5 is continuously expressed across the length of a blood vessel, but was discontinuous in many of the samples taken from individuals with schizophrenia (Figure 5f).